BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15155543)

  • 1. Evaluation of two nonisotopic immunoassays for determination of glutamic acid decarboxylase and tyrosine phosphatase autoantibodies in serum.
    Palomer X; Mauricio D; Rodríguez-Espinosa J; Zapico E; Mayoral C; González-Sastre F; de Leiva A; Blanco-Vaca F
    Clin Chem; 2004 Aug; 50(8):1378-82. PubMed ID: 15155543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-resolved immunofluorometric dual-label assay for simultaneous detection of autoantibodies to GAD65 and IA-2 in children with type 1 diabetes.
    Ankelo M; Westerlund A; Blomberg K; Knip M; Ilonen J; Hinkkanen AE
    Clin Chem; 2007 Mar; 53(3):472-9. PubMed ID: 17259239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of autoantibodies to protein tyrosine phosphatase-like protein IA-2 with a novel time-resolved fluorimetric assay.
    Westerlund-Karlsson A; Suonpää K; Ankelo M; Ilonen J; Knip M; Hinkkanen AE
    Clin Chem; 2003 Jun; 49(6 Pt 1):916-23. PubMed ID: 12765988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
    Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
    Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
    Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
    Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of autoantibodies to the diabetes-associated antigen IA-2 by a sensitive enzyme-linked immunosorbent assay.
    Löbner K; Khoo-Morgenthaler UY; Seissler J; Morgenthaler NG; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):686-91. PubMed ID: 10668923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined measurement of diabetes mellitus immunological markers: an assessment of its benefits in adult-onset patients.
    Valdez SN; Sica MP; Labovsky V; Iacono RF; Cardoso AL; Krochik AG; Mazza CS; Ermácora MR; Cédola N; Poskus E
    Autoimmunity; 2001; 33(4):227-36. PubMed ID: 11683397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
    Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays.
    Lind A; Freyhult E; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Larsson HE; Lundgren M; Carlsson A; Nilsson AL; Fex M; Törn C; Agardh D; Tsai CT; Lernmark Å;
    EBioMedicine; 2024 Jun; 104():105144. PubMed ID: 38723553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J; Seidel D; Schenker M; Ziegler AG
    Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly-sensitive and specific enzyme-linked immunosorbent assays for GAD65 autoantibodies using a thioredoxin-GAD65 fusion antigen.
    Papouchado ML; Valdez SN; Ermácora MR; Gañan S; Poskus E
    J Immunol Methods; 1997 Sep; 207(2):169-78. PubMed ID: 9368643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
    Wahlberg J; Fredriksson J; Nikolic E; Vaarala O; Ludvigsson J;
    Pediatr Diabetes; 2005 Dec; 6(4):199-205. PubMed ID: 16390388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2.
    Zavialov A; Ankelo M; Westerlund-Karlsson A; Knip M; Ilonen J; Hinkkanen A
    J Immunol Methods; 2000 Dec; 246(1-2):91-6. PubMed ID: 11121550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
    Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
    J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.